Tucatinib - Array BioPharma/Seagen
At a glance
- Drug Originator Array BioPharma
- Drug Licenced by Merck & Co; Seagen
- Drug Class 2 ring heterocyclic compounds; Antineoplastics; Diamines; Oxazoles; Pyridines; Quinazolines; Small molecules; Triazoles
- Mechanism of Action ERBB 2 receptor antagonists; Phosphorylation inhibitors
- USA Patent Applicants SEAGEN
- USA Patents 9
- NDAs 1
- International Patents 182
- Patent Applications 108
Table of Contents
Disclaimer